Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Keybanc analyst Matthew Gillmor maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $270 to $300.
Keybanc analyst Matthew Gillmor maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $270 to $300.